Denali Therapeutics Q3 2019 Earnings Report

Total Revenue
$13.6M
Previous year: $1.2M
+1038.4%
EPS
-$0.48
Previous year: -$0.38
+26.3%

Denali Therapeutics

Denali Therapeutics

Denali Therapeutics Revenue by Segment